Does Cognitive Dysfunction after Carotid Endarterectomy Vary by Statin Type or Dose?

Area of Science:

• Neurology
• Cardiovascular Surgery
• Pharmacology

Background:

• Asymptomatic carotid endarterectomy (CEA) patients on statins show reduced perioperative neurologic injury.
• Early cognitive dysfunction (eCD) and stroke are key concerns following CEA.

Purpose of the Study:

• To investigate if statin type or dose influences the incidence of eCD 24 hours after asymptomatic CEA.
• To identify specific statins or dosages that may offer neuroprotection during CEA.

Main Methods:

• Observational study of 324 patients undergoing asymptomatic CEA.
• Neuropsychometric testing pre-operatively and 24 hours post-operatively.
• Analysis of eCD incidence based on pre-operative statin use (type and dose).

Main Results:

• Patients on pravastatin and fluvastatin had no eCD.
• Simvastatin showed lower eCD incidence than atorvastatin (3.0% vs. 16.0%, P=0.005).
• Maximal statin doses significantly reduced eCD compared to sub-maximal doses (2.7% vs. 15.9%, P=0.002).

Conclusions:

• Statin type and maximal dosage appear to influence eCD incidence post-CEA.
• Physicochemical properties of statins (e.g., lipophilicity) may explain variations in neuroprotection.
• Further randomized trials are warranted to confirm optimal statin strategies for CEA patients.